Your browser doesn't support javascript.
loading
Optimization of lyoprotectant for recombinant human acidic fibroblast growth factor by response surface methodology.
Huang, Qiwen; Hu, Jing; Mei, Dongjie; Li, Guopan; Rong, Jun.
Afiliação
  • Huang Q; College of Life Science, Yangtze University, Jingzhou, PR China.
  • Hu J; College of Life Science, Yangtze University, Jingzhou, PR China.
  • Mei D; College of Life Science, Yangtze University, Jingzhou, PR China.
  • Li G; College of Life Science, Yangtze University, Jingzhou, PR China.
  • Rong J; Jingzhou Changxin Biotechnology Co, Ltd, Jingzhou, PR China.
Prep Biochem Biotechnol ; : 1-11, 2024 Jul 19.
Article em En | MEDLINE | ID: mdl-39028537
ABSTRACT
Recombinant human acidic fibroblast growth factor (rh-aFGF) is a widely used biological product, but it is unstable and its biological activity is easy to decrease. In order to maintain the long-term stability and biological activity of rh-aFGF, based on the response surface method, the freeze-drying characterization and cell proliferation rate of rh-aFGF freeze-dried powder were evaluated by scoring and Methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay in this study. The optimal concentrations of trehalose, glycine and BSA were optimized, and the optimal formulation was verified by regression experiment. The results showed that trehalose, glycine and BSA had significant effects on the characterization of lyophilized rh-aFGF and cell proliferation. The optimal formulation of 5.7% trehalose, 2.04% glycine and 1.98%BSA combined with rh-aFGF could achieve the optimal freeze-dried characterization and biological activity. Using the best formulation to verify, the freeze-dried formability index of the freeze-dried powder was 23.35, and the rate of cell proliferation was 43.59%, which was close to the expected 23 and 41.69%. This study determined a freeze-dried formulation of rh-aFGF that meets the requirements of freeze-dried formalization integrity and maintains biological activity, providing reliable support for the subsequent development of related drugs.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Prep Biochem Biotechnol Assunto da revista: BIOQUIMICA / BIOTECNOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Prep Biochem Biotechnol Assunto da revista: BIOQUIMICA / BIOTECNOLOGIA Ano de publicação: 2024 Tipo de documento: Article